These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19491656)

  • 1. Effects of epigallocatechin gallate on the oral bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats.
    Shin SC; Choi JS
    Anticancer Drugs; 2009 Aug; 20(7):584-8. PubMed ID: 19491656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of curcumin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen, in rats: possible role of CYP3A4 and P-glycoprotein inhibition by curcumin.
    Cho YA; Lee W; Choi JS
    Pharmazie; 2012 Feb; 67(2):124-30. PubMed ID: 22512082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of baicalein on the pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats: possible role of cytochrome P450 3A4 and P-glycoprotein inhibition by baicalein.
    Li C; Kim M; Choi H; Choi J
    Arch Pharm Res; 2011 Nov; 34(11):1965-72. PubMed ID: 22139696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of oral kaempferol on the pharmacokinetics of tamoxifen and one of its metabolites, 4-hydroxytamoxifen, after oral administration of tamoxifen to rats.
    Piao Y; Shin SC; Choi JS
    Biopharm Drug Dispos; 2008 May; 29(4):245-9. PubMed ID: 18338336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of morin on the bioavailability of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats.
    Shin SC; Piao YJ; Choi JS
    In Vivo; 2008; 22(3):391-5. PubMed ID: 18610753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oral epigallocatechin gallate on the oral pharmacokinetics of verapamil in rats.
    Chung JH; Choi DH; Choi JS
    Biopharm Drug Dispos; 2009 Mar; 30(2):90-3. PubMed ID: 19226653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of oral epigallocatechin gallate on the pharmacokinetics of nicardipine in rats.
    Choi JS; Burm JP
    Arch Pharm Res; 2009 Dec; 32(12):1721-5. PubMed ID: 20162400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats.
    Shin SC; Choi JS; Li X
    Int J Pharm; 2006 Apr; 313(1-2):144-9. PubMed ID: 16516418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced tamoxifen bioavailability after oral administration of tamoxifen in rats pretreated with naringin.
    Choi JS; Kang KW
    Arch Pharm Res; 2008 Dec; 31(12):1631-6. PubMed ID: 19099234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced bioavailability of tamoxifen and its metabolite 4-hydroxytamoxifen after oral administration with biochanin A (an isoflavone) in rats.
    Singh SP; Wahajuddin ; Raju KS; Ali MM; Kohli K; Jain GK
    Phytother Res; 2012 Feb; 26(2):303-7. PubMed ID: 22131128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of silybinin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen in rats.
    Kim CS; Choi SJ; Park CY; Li C; Choi JS
    Anticancer Res; 2010 Jan; 30(1):79-85. PubMed ID: 20150620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of myricetin, an anticancer compound, on the bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats.
    Li C; Lim SC; Kim J; Choi JS
    Eur J Drug Metab Pharmacokinet; 2011 Sep; 36(3):175-82. PubMed ID: 21442417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced bioavailability of etoposide after oral or intravenous administration of etoposide with kaempferol in rats.
    Li C; Li X; Choi JS
    Arch Pharm Res; 2009 Jan; 32(1):133-8. PubMed ID: 19183886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of epigallocatechin gallate on the bioavailability and pharmacokinetics of diltiazem in rats.
    Li C; Choi JS
    Pharmazie; 2008 Nov; 63(11):815-8. PubMed ID: 19069242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of lovastatin on the pharmacokinetics of verapamil and its active metabolite, norverapamil in rats: possible role of P-glycoprotein inhibition by lovastatin.
    Hong SP; Chang KS; Koh YY; Choi DH; Choi JS
    Arch Pharm Res; 2009 Oct; 32(10):1447-52. PubMed ID: 19898809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of prednisolone on the pharmacokinetics of loratadine after oral and intravenous administration of loratadine in rats.
    Li C; Kim M; Choi JS
    Arch Pharm Res; 2010 Sep; 33(9):1395-400. PubMed ID: 20945138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of baicalein, an antioxidant, on the bioavailability of doxorubicin in rats: possible role of P-glycoprotein inhibition by baicalein.
    Shin SC; Li C; Choi JS
    Pharmazie; 2009 Sep; 64(9):579-83. PubMed ID: 19827298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of silybinin, CYP3A4 and P-glycoprotein inhibitor in vitro, on the bioavailability of loratadine in rats.
    Li C; Lee MY; Choi JS
    Pharmazie; 2010 Jul; 65(7):510-4. PubMed ID: 20662320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and bioavailability of the bioflavonoid biochanin A: effects of quercetin and EGCG on biochanin A disposition in rats.
    Moon YJ; Morris ME
    Mol Pharm; 2007; 4(6):865-72. PubMed ID: 17970592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tesmilifene, a substrate of CYP3A and an inhibitor of P-glycoprotein, on the pharmacokinetics of intravenous and oral docetaxel in rats.
    Choi YH; Suh JH; Lee JH; Cho IH; Lee MG
    J Pharm Pharmacol; 2010 Aug; 62(8):1084-8. PubMed ID: 20663044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.